Bariatric Surgery Devices Market - Market Share, Industry Analysis with Key Companies 2024-2031

Bariatric Surgery Devices Market Outlook, Opportunities and Forecast 2024-2031

<h2>Global Bariatric Surgery Devices Market is segmented By Device Type (Assisting Devices, Implantable Devices), By Surgery Type (Sleeve Gastrectomy, Roux-en-Y Gastric Bypass(RYGB), Duodenal Switch, Revisional Surgery, Laparoscopic Adjustable Gastric Banding, Others), By End User (Hospitals, Ambulatory Surgery Centers, Others), By Region (North America, South America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Size, Share Outlook, and Opportunity Analysis, 2024-2031</h2>

&nbsp;

<h3>Report Overview</h3>

<blockquote>
Bariatric Surgery Devices Market is expected to grow at a&nbsp;CAGR of 5%&nbsp;during the forecast period (2024-2031).&nbsp;
</blockquote>

Bariatric surgical procedures reduce weight by restricting the amount of food the stomach can hold, causing malabsorption of nutrients, or combining gastric restriction and malabsorption. Most weight-loss surgeries are performed using minimally invasive techniques. People can reduce their weight by 15 to 30 percent of their starting weight on average, depending on the type of surgery they opt. Surgeons use various devices during the procedure depending upon the type of surgery.&nbsp;

The Bariatric Surgery Devices Market study analysis offers an in-depth outlook on the market containing both quantitative, and qualitative data. It gives an outlook and forecast of the global market based on the market segmentation by device&nbsp;type, surgery type, and end user. It also provides bariatric surgery devices market&nbsp;size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global bariatric surgery devices market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

&nbsp;

<h3>Bariatric Surgery Devices Market Summary</h3>

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			5%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Device Type, By Surgery Type, By End User, and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For More Insights <a href="https://www.datamintelligence.com/download-sample/bariatric-surgery-devices-market" target="_blank">Request free Sample</a>

&nbsp;

<h3>Bariatric Surgery Devices Market&nbsp;Dynamics</h3>

Emerging technology in robotic bariatric surgery is expected to drive market growth.

Morbid obesity is becoming more common in the United States and worldwide. In the United States, 65% of adults are classified as overweight (BMI &gt;25) or obese (BMI &gt;30). The majority of the rise is in the obese population, with more than 6% being severely obese (BMI greater than 40). Surgical technology advancements have enabled procedures to be conducted safely using less invasive approaches. They have improved the outcomes of bariatric surgery to the point where it is now superior to intensive medical therapy in terms of both weight reduction and overall long-term mortality, even when perioperative morbidity and mortality are considered.

For instance, <a href="https://www.datamintelligence.com/research-report/sleeve-gastrectomy-devices-market" target="_blank">sleeve gastrectomy</a> and Roux-en-Y gastric bypass are both laparoscopic and, more recently, robotic procedures. Studies comparing laparoscopic and robotic operations reveal comparable morbidity, mortality, and weight loss results. However, technological complications may develop when operating on individuals with BMIs greater than 50. These patients face anatomical problems, such as strong abdominal walls (especially in female patients), which may necessitate excessive torque to the laparoscopic trocars and tools, resulting in tissue trauma, less precise motions, and surgeon fatigue. In addition, achieving pneumoperitoneum in superobese patients is more challenging, necessitating higher insufflation pressures and narrower intra-abdominal working space, making delicate dissection difficult.

Therefore, the wristed, 3-dimensional movements and high-definition magnified views achieved by the DaVinci robotic instruments and cameras allow surgeons to use this platform to overcome these technical challenges. Furthermore, the robotic arms have precise movements with enough mechanical power to minimize the torque required to maneuver surgical instruments and minimize the risk of trauma to the abdominal wall, resulting in less postoperative pain and a faster recovery. Thus, the robotic platform has now proven to be as safe and effective as the traditional laparoscopic procedure, which has driven the practice and safety of bariatric surgery.

<h3>Restraint:</h3>

The costly surgical procedures, post-operative consequences, and lack of skilled professionals hamper the global adoption of bariatric surgery devices over the forecast period. For instance, blood clots, infection, bleeding, constipation, and gallstones, among other side effects of bariatric surgery, are major issues preventing individuals from undergoing surgery for weight loss. Furthermore, post-operative hazards are very common in patients, including acid reflux, protein or calorie deficiency, gallstones, constipation, stomach obstruction, and so on. Several studies also reveal greater mental health hazards. It is believed that more than 20% of patients considering and following bariatric surgery have behavioral health issues such as anxiety, binge-eating disorder, and depression, among others.

<h3>Industry Analysis</h3>

The bariatric surgery Devices market provides in-depth analysis of the market based on various industry factors such as porter five forces, unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

&nbsp;

<h3>Bariatric Surgery Devices Market&nbsp;Segmentation Analysis</h3>

<h3>Sleeve Gastrectomy segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)</h3>

Sleeve gastrectomy is a safe and effective bariatric surgery to help obese people lose weight. Sleeve gastrectomy may be performed as a single procedure or as the initial stage before a gastric bypass. Sleeve gastrectomy includes an average weight loss of more than 50% of excess body weight, preserved stomach function because the nerves of the stomach and the outlet valve are not changed, and a lower risk of developing vitamin and mineral deficiencies because the food you eat follows the normal digestive path.

Moreover, the surgeon only uses the <a href="https://www.datamintelligence.com/research-report/laparoscopic-instruments-market" target="_blank">laparoscopic</a> approach for sleeve gastrectomy surgery due to the many benefits of laparoscopic surgery, which include less pain and a lower need for pain medication, a lower risk of wound infection, a quicker recovery and return to daily activities, several small incisions rather than a large one, and shorter hospital stays. Additionally, in June 2021, Standard Bariatrics, Inc. launched Titan SGS. This device aids surgeons in sleeve gastrectomy, with the industry&#39;s longest continuous staple cutline of 23 centimeters, and is the most frequently used bariatric surgery for obesity. Therefore, it has increased the demand for sleeve gastrectomy procedures. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

&nbsp;

<h3>COVID-19 Impact On&nbsp;Bariatric Surgery Devices Market</h3>

The ongoing COVID-19 pandemic has strongly affected the delivery of surgical care worldwide. COVID-19, influenced by lockdown and work-from-home adoption, will increase sedentary lifestyles, resulting in a more obese population and expanding the potential for the bariatric surgical devices industry. Moreover, elective procedures have been postponed to reallocate resources to COVID-19 patients. Preoperative upper gastrointestinal tract endoscopies, outpatient clinic appointments, and bariatric procedures were all postponed by the majority of respondents.

Instead of meeting patients in outpatient clinics, most surgeons use video conferencing for follow-up sessions. Although laparoscopy remained the recommended treatment for surgical emergencies, there was a tendency toward conservative treatment of acute appendicitis and acute cholecystitis. Because rapid preoperative COVID-19 testing was not commonly available, routine screening of emergency bariatric cases was not frequently performed. The participants used a wide range of safeguards and personal safety equipment.

Additionally, the pandemic interrupted the supply chain for bariatric surgery devices. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

&nbsp;

<h3>Bariatric Surgery Devices Market&nbsp;Geographical Share</h3>

<h3>North American region holds the largest market share of the global bariatric surgery devices market.</h3>

In 2021, the North American region accounted for the largest market share. The increasing prevalence of obesity, technological advancements in bariatric surgery devices, and rising awareness regarding obesity in the region are the factors driving the market in the forecast period. For instance, many Americans have put on a lot of weight since the COVID-19 crisis began, probably due to a rise in sedentary behavior, stress, and issues like job and income loss that make healthy eating challenging.

Moreover, the obesity rate in the general population is expected to reach around 42% by 2020, with the obesity rate increasing year after year, leading to an increase in the incidence of chronic diseases in adults. Obesity can cause serious health concerns and a considerable increase in mortality and morbidity. The region also has a substantially higher acceptance rate for weight loss surgery procedures, which helps the industry drive.

Additionally, Grantmakers In Health (GIH), an educational nonprofit dedicated to assisting foundations and corporate giving programs in improving the health of all people by strengthening the grantmaking community&#39;s knowledge, skills, and effectiveness, has been working to reduce childhood obesity rates for over a decade. GIH has recently concentrated on policy formulation and boosting access to nutritious food and physical activity.

Furthermore, GIH uses a variety of platforms to bring together grantmakers and health experts and provide instructional materials, including meetings, forums, webinars, and publications. Recent GIH programming on childhood obesity has focused on the role of early childhood and childcare interventions. These discussions focused on early childhood obesity prevention strategies, highlighting recent accomplishments, ongoing problems, and areas where philanthropic support may impact sensible policy change that would give families enhanced child health support and involvement.

&nbsp;

<h3>Bariatric Surgery Devices Companies</h3>

Major key players in the bariatric surgery devices market are ReShape Lifesciences, Inc., Covidien Plc, Johnson and Johnson, Cousin Biotech, <a href="https://mediflex.com/collections/bariatric" target="_blank">Mediflex Surgical</a>, Intuitive Surgical Inc., GI Dynamics Inc., TransEnterix Inc., USGI Medical Inc., and Semiled Ltd.

ReShape Lifesciences, Inc.:

Overview:

ReShape Lifesciences is America&rsquo;s premier weight-loss solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy.

The ReShape Vest System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The recently launched ReShapeCare Virtual health coaching program is a virtual telehealth weight management program that supports lifestyle changes for all weight-loss patients to help them keep the weight off over time.

&shy;Product Portfolio: 

Lap-Band System: The Lap-Band System is indicated for weight reduction for patients with obesity, with a Body Mass Index (BMI) of at least 40 kg/m2 or a BMI of at least 30 kg/m2 with one or more obesity-related comorbid conditions. It is indicated for use only in adult patients who have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modification programs.

The global bariatric surgery devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

<ol>
	<li>Methodology and Scope
	<ol>
		<li>Research methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Market Definition and Overview</li>
	<li>Executive Summary
	<ol>
		<li>Market Snippet by Device Type&nbsp;&nbsp;</li>
		<li>Market Snippet by Surgery Type</li>
		<li>Market Snippet by End User</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors</li>
		<li>Drivers
		<ol>
			<li>Increasing Number Of Bariatric Surgeries</li>
			<li>Increasing Prevalence of Obesity</li>
		</ol>
		</li>
		<li>Restraints
		<ol>
			<li>Cost Of Surgeries And Post-Operative Consequences</li>
		</ol>
		</li>
		<li>Impact Analysis</li>
	</ol>
	</li>
	<li>Industry Analysis&nbsp;&nbsp;
	<ol>
		<li>Porter&#39;s Five Forces Analysis&nbsp;&nbsp;</li>
		<li>Pricing Analysis</li>
	</ol>
	</li>
	<li>by Device Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Device Type</li>
			<li>Market Attractiveness Index, by Device Type</li>
		</ol>
		</li>
		<li>Assisting Devices
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)
			<ol>
				<li>Stapling devices&nbsp;&nbsp;</li>
				<li>Closure devices</li>
				<li>Suturing devices</li>
				<li>Other Devices</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Implantable Devices
		<ol>
			<li>Electrical Simulation devices</li>
			<li>Gastric Bands</li>
			<li>Gastric Emptying Devices</li>
			<li>Other Devices</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>by Surgery Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Surgery Type</li>
			<li>Market Attractiveness Index, by Surgery Type</li>
		</ol>
		</li>
		<li>Sleeve Gastrectomy
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Roux-en-Y Gastric Bypass(RYGB)</li>
		<li>Duodenal Switch</li>
		<li>Revisional Surgery</li>
		<li>Laparoscopic Adjustable Gastric Banding</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By End User
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by End User</li>
			<li>Market Attractiveness Index, by End User</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Ambulatory Surgery Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Region
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Device Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Surgery Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By&nbsp;Countries &nbsp;
			<ol>
				<li>The U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Device Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Surgery Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By&nbsp;Countries &nbsp;
			<ol>
				<li>Germany</li>
				<li>The U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Device Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Surgery Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by&nbsp;Countries &nbsp;
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Device Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Surgery Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by&nbsp;Countries &nbsp;
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>The Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Device Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), by Surgery Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Competitive Landscape
	<ol>
		<li>Competitive Scenario</li>
		<li>Competitor Strategy Analysis</li>
		<li>Comparative Product Portfolio Analysis</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>&ndash;&nbsp;Company Profiles
	<ol>
		<li>Allergan Inc.*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio And Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Medtronic Plc</li>
		<li>Johnson And Johnson Company</li>
		<li>Intuitive Surgical Inc.</li>
		<li>Gi Dynamics Inc</li>
		<li>Transenterix Inc</li>
		<li>Usgi Medical Inc</li>
		<li>Semileds Ltd</li>
		<li>Cousin Biotech</li>
		<li>Mediflex Surgical Procedures.</li>
	</ol>
	</li>
	<li>
	DataM Intelligence

	<ol>
		<li>Appendix</li>
		<li>List of Tables and Figures</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Bariatric Surgery Devices Market Value, By Device Type, 2023, 2027 &amp; 2031 ($ Million)

Table 2 Global Bariatric Surgery Devices Market Value, By Surgery Type, 2023, 2027 &amp; 2031 ($ Million)

Table 3 Global Bariatric Surgery Devices Market Value, By End User, 2023, 2027 &amp; 2031 ($ Million)

Table 4 Global Bariatric Surgery Devices Market Value, By Region, 2023, 2027 &amp; 2031 ($ Million)

Table 5 Global Bariatric Surgery Devices Market Value, By Device Type, 2023, 2027 &amp; 2031 ($ Million)

Table 6 Global Bariatric Surgery Devices Market Value, By Device Type, 2022-2031 ($ Million)

Table 7 Global Bariatric Surgery Devices Market Value, By Surgery Type, 2023, 2027 &amp; 2031 ($ Million)

Table 8 Global Bariatric Surgery Devices Market Value, By Surgery Type, 2022-2031 ($ Million)

Table 9 Global Bariatric Surgery Devices Market Value, By End User, 2023, 2027 &amp; 2031 ($ Million)

Table 10 Global Bariatric Surgery Devices Market Value, By End User, 2022-2031 ($ Million)

Table 11 Global Bariatric Surgery Devices Market Value, By Region, 2023, 2027 &amp; 2031 ($ Million)

Table 12 Global Bariatric Surgery Devices Market Value, By Region, 2022-2031 ($ Million)

Table 13 North America Bariatric Surgery Devices Market Value, By Device Type, 2022-2031 ($ Million)

Table 14 North America Bariatric Surgery Devices Market Value, By Surgery Type, 2022-2031 ($ Million)

Table 15 North America Bariatric Surgery Devices Market Value, By End User, 2022-2031 ($ Million)

Table 16 North America Bariatric Surgery Devices Market Value, By Country, 2022-2031 ($ Million)

Table 17 South America Bariatric Surgery Devices Market Value, By Device Type, 2022-2031 ($ Million)

Table 18 South America Bariatric Surgery Devices Market Value, By Surgery Type, 2022-2031 ($ Million)

Table 19 South America Bariatric Surgery Devices Market Value, By End User, 2022-2031 ($ Million)

Table 20 South America Bariatric Surgery Devices Market Value, By Country, 2022-2031 ($ Million)

Table 21 Europe Bariatric Surgery Devices Market Value, By Device Type, 2022-2031 ($ Million)

Table 22 Europe Bariatric Surgery Devices Market Value, By Surgery Type, 2022-2031 ($ Million)

Table 23 Europe Bariatric Surgery Devices Market Value, By End User, 2022-2031 ($ Million)

Table 24 Europe Bariatric Surgery Devices Market Value, By Country, 2022-2031 ($ Million)

Table 25 Asia-Pacific Bariatric Surgery Devices Market Value, By Device Type, 2022-2031 ($ Million)

Table 26 Asia-Pacific Bariatric Surgery Devices Market Value, By Surgery Type, 2022-2031 ($ Million)

Table 27 Asia-Pacific Bariatric Surgery Devices Market Value, By End User, 2022-2031 ($ Million)

Table 28 Asia-Pacific Bariatric Surgery Devices Market Value, By Country, 2022-2031 ($ Million)

Table 29 Middle East &amp; Africa Bariatric Surgery Devices Market Value, By Device Type, 2022-2031 ($ Million)

Table 30 Middle East &amp; Africa Bariatric Surgery Devices Market Value, By Surgery Type, 2022-2031 ($ Million)

Table 31 Middle East &amp; Africa Bariatric Surgery Devices Market Value, By End User, 2022-2031 ($ Million)

Table 32 Allergan Inc.: Overview

Table 33 Allergan Inc.: Product Portfolio

Table 34 Allergan Inc.: Key Developments

Table 35 Medtronic Plc: Overview

Table 36 Medtronic Plc: Product Portfolio

Table 37 Medtronic Plc: Key Developments

Table 38 Johnson and Johnson Company: Overview

Table 39 Johnson and Johnson Company: Product Portfolio

Table 40 Johnson and Johnson Company: Key Developments

Table 41 Intuitive Surgical Inc.: Overview

Table 42 Intuitive Surgical Inc.: Product Portfolio

Table 43 Intuitive Surgical Inc.: Key Developments

Table 44 GI Dynamics Inc: Overview

Table 45 GI Dynamics Inc: Product Portfolio

Table 46 GI Dynamics Inc: Key Developments

Table 47 TransEnterix Inc: Overview

Table 48 TransEnterix Inc: Product Portfolio

Table 49 TransEnterix Inc: Key Developments

Table 50 USGI Medical Inc: Overview

Table 51 USGI Medical Inc: Product Portfolio

Table 52 USGI Medical Inc: Key Developments

Table 53 SemiLEDs Ltd: Overview

Table 54 SemiLEDs Ltd: Product Portfolio

Table 55 SemiLEDs Ltd: Key Developments

Table 56 Cousin Biotech: Overview

Table 57 Cousin Biotech: Product Portfolio

Table 58 Cousin Biotech: Key Developments

Table 59 Mediflex Surgical Procedures: Overview

Table 60 Mediflex Surgical Procedures: Product Portfolio

Table 61 Mediflex Surgical Procedures: Key Developments

&nbsp;

List of Figures&nbsp;

Figure 1 Global Bariatric Surgery Devices Market Share, By Device Type, 2022 &amp; 2031 (%)

Figure 2 Global Bariatric Surgery Devices Market Share, By Surgery Type, 2022 &amp; 2031 (%)

Figure 3 Global Bariatric Surgery Devices Market Share, By End User, 2022 &amp; 2031 (%)

Figure 4 Global Bariatric Surgery Devices Market Share, By Region, 2022 &amp; 2031 (%)

Figure 5 Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 6 Global Bariatric Surgery Devices Market Y-o-Y Growth, By Device Type, 2022-2031 (%)

Figure 7 Assisting Devices: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 8 Implantable Devices: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 9 Global Bariatric Surgery Devices Market Y-o-Y Growth, By Surgery Type, 2022-2031 (%)

Figure 10 Sleeve Gastrectomy: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 11 Roux-en-Y Gastric Bypass: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 12 Duodenal Switch: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 13 Revisional Surgery: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 14 Laparoscopic Adjustable Gastric Banding: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 15 Others: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 16 Global Bariatric Surgery Devices Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 17 Hospitals: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 18 Ambulatory Surgery Centers: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 19 Others: Global Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 20 Global Bariatric Surgery Devices Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 21 North America Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 22 North America Bariatric Surgery Devices Market Share, By Device Type, 2022 &amp; 2031 (%)

Figure 23 North America Bariatric Surgery Devices Market Share, By Surgery Type, 2022 &amp; 2031 (%)

Figure 24 North America Bariatric Surgery Devices Market Share, By End User, 2022 &amp; 2031 (%)

Figure 25 North America Bariatric Surgery Devices Market Share, By Country, 2022 &amp; 2031 (%)

Figure 26 South America Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 27 South America Bariatric Surgery Devices Market Share, By Device Type, 2022 &amp; 2031 (%)

Figure 28 South America Bariatric Surgery Devices Market Share, By Surgery Type, 2022 &amp; 2031 (%)

Figure 29 South America Bariatric Surgery Devices Market Share, By End User, 2022 &amp; 2031 (%)

Figure 30 South America Bariatric Surgery Devices Market Share, By Country, 2022 &amp; 2031 (%)

Figure 31 Europe Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 32 Europe Bariatric Surgery Devices Market Share, By Device Type, 2022 &amp; 2031 (%)

Figure 33 Europe Bariatric Surgery Devices Market Share, By Surgery Type, 2022 &amp; 2031 (%)

Figure 34 Europe Bariatric Surgery Devices Market Share, By End User, 2022 &amp; 2031 (%)

Figure 35 Europe Bariatric Surgery Devices Market Share, By Country, 2022 &amp; 2031 (%)

Figure 36 Asia-Pacific Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 37 Asia-Pacific Bariatric Surgery Devices Market Share, By Device Type, 2022 &amp; 2031 (%)

Figure 38 Asia-Pacific Bariatric Surgery Devices Market Share, By Surgery Type, 2022 &amp; 2031 (%)

Figure 39 Asia-Pacific Bariatric Surgery Devices Market Share, By End User, 2022 &amp; 2031 (%)

Figure 40 Asia-Pacific Bariatric Surgery Devices Market Share, By Country, 2022 &amp; 2031 (%)

Figure 41 Middle East &amp; Africa Bariatric Surgery Devices Market Value, 2022-2031 ($ Million)

Figure 42 Middle East &amp; Africa Bariatric Surgery Devices Market Share, By Device Type, 2022 &amp; 2031 (%)

Figure 43 Middle East &amp; Africa Bariatric Surgery Devices Market Share, By Surgery Type, 2022 &amp; 2031 (%)

Figure 44 Middle East &amp; Africa Bariatric Surgery Devices Market Share, By End User, 2022 &amp; 2031 (%)

Figure 45 Allergan Inc.: Financials

Figure 46 Medtronic Plc: Financials

Figure 47 Johnson and Johnson Company: Financials

Figure 48 Intuitive Surgical Inc.: Financials

Figure 49 GI Dynamics Inc: Financials

Figure 50 TransEnterix Inc: Financials

Figure 51 USGI Medical Inc: Financials

Figure 52 SemiLEDs Ltd: Financials

Figure 53 Cousin Biotech: Financials

Figure 54 Mediflex Surgical Procedures: Financials